Richard C. Young & CO. LTD. Decreases Position in Colgate-Palmolive Company $CL

Richard C. Young & CO. LTD. lowered its stake in Colgate-Palmolive Company (NYSE:CL) by 82.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 17,551 shares of the company’s stock after selling 80,092 shares during the quarter. Richard C. Young & CO. LTD.’s holdings in Colgate-Palmolive were worth $1,403,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CL. Tiemann Investment Advisors LLC grew its position in Colgate-Palmolive by 2.1% in the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after acquiring an additional 125 shares in the last quarter. Westside Investment Management Inc. boosted its stake in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the period. S.A. Mason LLC grew its holdings in Colgate-Palmolive by 3.9% during the 3rd quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after purchasing an additional 130 shares in the last quarter. Security National Bank of Sioux City Iowa IA increased its stake in Colgate-Palmolive by 0.8% during the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock worth $1,298,000 after buying an additional 130 shares during the period. Finally, Stratos Wealth Advisors LLC lifted its holdings in Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after buying an additional 130 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In related news, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the sale, the insider owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Panagiotis Tsourapas sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the transaction, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. This represents a 59.02% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 184,683 shares of company stock worth $17,486,693 in the last ninety days. Insiders own 0.41% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of analyst reports. Rothschild & Co Redburn set a $93.00 target price on Colgate-Palmolive in a research report on Friday, February 13th. Deutsche Bank Aktiengesellschaft raised their price objective on Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Jefferies Financial Group upped their target price on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. UBS Group raised their price target on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Finally, Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $95.34 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The company has a market capitalization of $76.85 billion, a price-to-earnings ratio of 36.39, a price-to-earnings-growth ratio of 4.39 and a beta of 0.28. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The business has a 50 day simple moving average of $88.16 and a 200-day simple moving average of $82.85.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter in the previous year, the company posted $0.91 earnings per share. The firm’s revenue was up 5.8% on a year-over-year basis. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Colgate-Palmolive News Summary

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Colgate is expanding its AI push under Iraklis “Kli” Pappas to get employees using AI beyond basic tasks — a potential productivity and innovation catalyst that could help margin and SG&A efficiencies over time. The AI Evangelist Shaking Up a 220-Year-Old Toothpaste Maker
• Neutral Sentiment: NY Fed’s John Williams cautioned it’s too early to judge the Iran war’s economic impact — that leaves uncertainty about near‑term inflation and growth but does not yet force a clear re‑rating for defensive consumer names. Fed’s Williams: too early to assess Iran war impact on US economy
• Neutral Sentiment: Market strategists note the S&P reaction over the next few sessions will determine whether the sell‑off is transient; momentum there could affect broad multiples that support consumer staples valuations. History says this is the critical question for the S&P 500 over the next few days
• Negative Sentiment: Former Treasury Sec. Janet Yellen warned the Iran conflict could raise inflation and slow growth, making the Fed more reluctant to cut — a higher‑for‑longer rates backdrop can pressure defensive multiple expansion and consumer spending. Yellen says Iran conflict puts Fed on hold, complicates rate cuts
• Negative Sentiment: Analysts (UBS, Barclays) flag that the Iran escalation risks derailing several trades and raising credit/AI worries — the resulting risk‑off could reduce demand or margin flexibility for consumer packaged goods. Iran Conflict: Which trades & themes are most at risk? Iran escalation compounds AI and credit worries, Barclays’ Cau warns
• Negative Sentiment: Higher oil risk premia have pushed banks to lift targets for oil majors — good for energy names but a headwind for Colgate via higher packaging, freight and input costs if elevated oil persists. Chevron, Exxon price targets raised at BofA on increased oil risk premium

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.